» Articles » PMID: 22822907

T Regulatory Cells Play a Significant Role in Modulating MHC Class I Antibody-induced Obliterative Airway Disease

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2012 Jul 25
PMID 22822907
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mechanisms leading to the development of chronic lung allograft dysfunction following de novo development of antibodies to mismatched donor MHC remain undefined. We demonstrated that intrabronchial administration of antibodies to MHC class I resulted in induction of both innate and adaptive cellular immune responses characterized by a predominance of Th17 specific to lung associated self-antigens Kα1-tubulin and Collagen-V leading to the development of obliterative airway lesions (OAD), correlate of chronic rejection following human lung transplantation. To determine the role of regulatory T cells (Treg) in the pathogenesis of OAD, we administered anti-MHC class I to mice, in which Treg were depleted by conditional ablation of FoxP3+cells. Under this condition, we observed a threefold increase in pulmonary cellular infiltration, luminal occlusion and fibrous deposition when compared anti-MHC class I Ab administered mice maintaining FoxP3. OAD lesions were accompanied with enhanced accumulation of neutrophils along with self-antigen-specific Th17 and humoral responses. However, IL-17-blockade or adoptive transfer of Treg abrogated OAD. We conclude that Treg exerts a suppressive effect on anti-MHC induced IL-8-mediated neutrophil infiltration and innate immune responses that leads to inhibition of Th17 immune responses to lung associated self-antigens which is critical for development of OAD.

Citing Articles

The role of lung-restricted autoantibodies in the development of primary and chronic graft dysfunction.

Yang W, Lecuona E, Wu Q, Liu X, Sun H, Alam H Front Transplant. 2024; 2:1237671.

PMID: 38993924 PMC: 11235341. DOI: 10.3389/frtra.2023.1237671.


Low-Salt Diet Reduces Anti-CTLA4 Mediated Systemic Immune-Related Adverse Events while Retaining Therapeutic Efficacy against Breast Cancer.

Khandekar D, Dahunsi D, Manzanera Esteve I, Reid S, Rathmell J, Titze J Biology (Basel). 2022; 11(6).

PMID: 35741331 PMC: 9219826. DOI: 10.3390/biology11060810.


Cancer Salt Nostalgia.

Allu A, Tiriveedhi V Cells. 2021; 10(6).

PMID: 34064273 PMC: 8224381. DOI: 10.3390/cells10061285.


Hyperlipidemia and Allograft Rejection.

Bagley J, Williams L, Hyde M, Rosa Birriel C, Iacomini J Curr Transplant Rep. 2020; 6(1):90-98.

PMID: 31934529 PMC: 6956651. DOI: 10.1007/s40472-019-0232-2.


IL-17A Contributes to Lung Fibrosis in a Model of Chronic Pulmonary Graft-versus-host Disease.

Martinu T, McManigle W, Kelly F, Nelson M, Sun J, Zhang H Transplantation. 2019; 103(11):2264-2274.

PMID: 31658231 PMC: 7550218. DOI: 10.1097/TP.0000000000002837.


References
1.
Saini D, Weber J, Ramachandran S, Phelan D, Tiriveedhi V, Liu M . Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant. 2011; 30(6):624-31. PMC: 3091959. DOI: 10.1016/j.healun.2011.01.708. View

2.
Saini D, Angaswamy N, Tiriveedhi V, Fukami N, Ramachandran S, Hachem R . Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation. J Heart Lung Transplant. 2010; 29(12):1330-6. PMC: 2991612. DOI: 10.1016/j.healun.2010.05.036. View

3.
Bharat A, Fields R, Steward N, Trulock E, Patterson G, Mohanakumar T . CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant. 2006; 6(8):1799-808. DOI: 10.1111/j.1600-6143.2006.01383.x. View

4.
Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G . Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med. 2007; 204(1):57-63. PMC: 2118432. DOI: 10.1084/jem.20061852. View

5.
Murphy C, Langrish C, Chen Y, Blumenschein W, Mcclanahan T, Kastelein R . Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003; 198(12):1951-7. PMC: 2194162. DOI: 10.1084/jem.20030896. View